All In MedTech

Device Trial Radar · NCT07675109

Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)

Form, Fit and Function Feasibility Study

Last checked: Nov 20, 2026Latest source record: Jun 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Jun 8, 2026

Primary completion

Dec 2026

Study completion Jun 2027

Sponsor

Lead sponsor
Noctrix Health, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 30, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms. The IRB has established that the investigational device is non-significant risk.

Conditions

  • Restless Legs Syndrome (RLS)

Interventions

  • Investigational Extended Duration (XD-) TOMAC TherapyDevice

    The investigational noninvasive neuromodulation device will be setup by the participant at bedtime and used to provide Extended Duration Tonic Motor Activation (XD-TOMAC) every night. The IRB has established that the investigational device is non-significant risk.

  • Tonic Motor Activation (TOMAC) TherapyDevice

    The noninvasive neuromodulation device will be setup by the participant to be used for TOMAC 30-minute stimulation therapy sessions as needed during the 2nd week of the study and as appropriate for the remainder of the study. The IRB has established that the device is non-significant risk.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of RLS-related awakenings per nightTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Noctrix Health Headquarters

    Pleasanton, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.